Cargando...
Clinical Trials in Metastatic Uveal Melanoma: Immunotherapy
BACKGROUND: Uveal melanoma (UM) is a rare subtype of melanoma that generally has a poor prognosis once it has metastasized. Clinical trials evaluating immune checkpoint inhibitors (ICIs) in UM have demonstrated response rates lower than those seen in cutaneous melanoma. Despite lower efficacy demons...
Gardado en:
| Publicado en: | Ocul Oncol Pathol |
|---|---|
| Autor Principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
S. Karger AG
2021
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8280448/ https://ncbi.nlm.nih.gov/pubmed/34307327 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000513336 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|